Hepatitis C virus and natural compounds: a new antiviral approach?
about
Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug targetHepatitis C virus: Promising discoveries and new treatmentsAntiviral activity of glycyrrhizin against hepatitis C virus in vitroVirocidal activity of Egyptian scorpion venoms against hepatitis C virus.Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.Complementary and alternative medications in hepatitis C infection.Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors.Depsides: lichen metabolites active against hepatitis C virusPlant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitroA Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian ArtichokeMitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress.Reactive oxygen and nitrogen species during viral infections.Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species.Anti-hepatitis C virus activity of crude extract and fractions of Entada africana in genotype 1b replicon systems.Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt.A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry.Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes.Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.The wild Egyptian artichoke as a promising functional food for the treatment of hepatitis C virus as revealed via UPLC-MS and clinical trials.Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery SystemsIn silico studies of medicinal compounds against hepatitis C capsid protein from north India.A plant-derived dehydrorotenoid: a new inhibitor of hepatitis C virus entry.Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus.Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle.Plant-derived antivirals against hepatitis c virus infection.A Review of the Ongoing Research on Zika Virus Treatment.Lanyamycin, a macrolide antibiotic from Sorangium cellulosum, strain Soce 481 (Myxobacteria).Determination of Flavonoids inStellariaby High-Performance Liquid Chromatography–Tandem Mass Spectrometry
P2860
Q27313291-A4CCADBF-DEA0-49AA-BC7D-FA204F974606Q27468916-D317E9CE-BFA9-4F1C-A8C7-D456AB64CEF1Q28534716-F3C25227-7AB3-48B5-A89B-647FA2E2BA15Q30389258-2818000A-7880-4DAB-ADE3-80C88DD1288CQ30393264-74FF6F34-83D2-40E4-9C64-2A8581446FBFQ34411345-BFB08BBD-E02E-4E7D-9420-9DACF47258FFQ35087842-718198B7-13D9-4A34-AD91-51DD32D26A3CQ35248674-37792609-B0EC-447C-9B40-B1278D8FDAE3Q35582646-4DF381AC-233D-4418-A477-B1125222B19BQ35609156-134F7BA0-DA8F-45B8-80F1-A76CD7D47CBCQ35778059-E545191A-D976-472F-9911-CCD7CC5816CBQ36524016-DDF62D9F-2DB0-4732-9967-55DCAE0DF315Q38174062-1AF15E9C-04DF-460E-BFD2-33429FB0C10FQ38231321-739AE099-B4CF-4063-9ED4-CE2BAA685BBFQ38850319-DB1C70A3-40F9-4596-A112-46C3513E76ACQ38860963-B21C6009-4253-41A2-8BE5-37AD7B8EB175Q38977067-FFF84016-417F-43F2-A3CD-5D98D8E18D20Q39685382-C25B306C-B42A-49F6-886E-BF6E1535E617Q40126459-C2D7F704-1301-4ACD-A3C5-E0B75F512740Q40150500-A8E8CA8A-E60C-4525-B97C-510026487E3AQ40215918-32726797-A06B-484F-B767-06D8CBECBA20Q40228338-307391DF-8176-4FCC-9396-5794FE356952Q40703891-7F220879-E254-4781-AD00-FA74CA03BF37Q40704664-18191C52-7974-476A-B0CF-D21CF048FC8EQ41169121-33BC2A40-132F-4BDF-B1F6-4A0336E5592FQ41539117-43914892-697C-4FC4-9159-ECD09CF4CE62Q41981846-8ED04C70-8125-4660-9A51-DC8630CD4271Q42242645-28221906-9EFD-49C6-B54C-98F9B876C220Q47218476-C629C46B-C0A7-496F-9D07-02A9BF4FD745Q49197977-8A404883-C1A1-4490-975A-E2B51148F2CBQ53682362-D2E6A68C-BB0D-4A8A-8460-B86110CE0B6FQ55716663-74F8EEC2-3341-4DD7-AD6D-BD0030F52160Q58175855-C0CA83F5-9B41-46D3-9DD5-51A3231431F8
P2860
Hepatitis C virus and natural compounds: a new antiviral approach?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatitis C virus and natural compounds: a new antiviral approach?
@en
type
label
Hepatitis C virus and natural compounds: a new antiviral approach?
@en
prefLabel
Hepatitis C virus and natural compounds: a new antiviral approach?
@en
P2860
P50
P356
P1433
P1476
Hepatitis C virus and natural compounds: a new antiviral approach?
@en
P2093
Noémie Calland
P2860
P304
P356
10.3390/V4102197
P577
2012-10-17T00:00:00Z